San Diego, CA, United States of America

Christopher L Reyes

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 69(Granted Patents)


Location History:

  • San Diego, CA (US) (2009 - 2020)
  • Thebarton, AU (2023)

Company Filing History:


Years Active: 2009-2023

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christopher L. Reyes in Cancer Treatment

Introduction: Christopher L. Reyes, based in San Diego, California, is a notable inventor in the field of cancer biology. With a remarkable portfolio of 12 patents, he has made significant strides in developing novel therapies aimed at treating cancer. His work emphasizes the need for innovative solutions in oncology, showcasing the importance of scientific research and development.

Latest Patents: Among his latest inventions, Christopher L. Reyes has developed a combination therapy that includes an antibody directed against cancer stem cells and a checkpoint inhibitor for the treatment of tumors in patients. This groundbreaking approach aims to enhance the effectiveness of cancer treatments by targeting specific cell types. Another noteworthy patent focuses on treating cancer through the administration of a humanized anti-LGR5 monoclonal antibody. This invention explores the administration of antibodies that specifically bind to LGR5 to address certain types of cancer, further highlighting his commitment to advancing cancer treatment methodologies.

Career Highlights: Christopher has worked with companies known for their innovative approaches in the medical and biotechnology fields, specifically at Bionomics Inc. and Biogen Idec. His experience at these organizations has allowed him to contribute to important research projects and innovations that have the potential to change the landscape of cancer treatment.

Collaborations: During his career, Christopher has collaborated with esteemed colleagues like Peter Chu and Christilyn Graff. Together, they have fostered an environment of innovation and collaboration that is critical to advancing research in targeted cancer therapies.

Conclusion: Christopher L. Reyes stands out as a pivotal figure in the realm of cancer treatment innovations. His extensive patent portfolio and collaborations with industry experts demonstrate his dedication to enhancing patient outcomes through groundbreaking research. His contributions reflect the continuous need for innovation in medical science, particularly in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…